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Development, psychometric properties and preliminary clinical validation of a brief, 
session-by-session measure of eating disorder cognitions and behaviors: The ED-15 
 
Abstract  
Objective: In the treatment research literature on other psychological disorders, there is a 
move towards session-by-session symptom measurement. The necessary measures need to 
be brief, focused on core features since the last session, and readily available to clinicians. 
There is no measure in the eating disorders that meets those criteria. This research reports 
the development and validation of such a self-report questionnaire.  
Method: The authors generated and refined a brief set of attitudinal and behavioral items. The 
resulting questionnaire (the ED-15) and an existing measure (Eating Disorders Examination-
Questionnaire; EDE-Q) were completed by a large non-clinical adult sample (N = 531), a group 
of self-reported eating disorder sufferers (N = 63), and a group of women (N = 33) diagnosed 
with bulimia nervosa or atypical bulimia nervosa and undertaking cognitive-behavioral therapy.  
Results: Factor analysis identified two scales (Weight & Shape Concerns; Eating Concerns), 
with strong internal consistency and test-retest reliability. Correlations with the EDE-Q (r = 
.889) indicates that the ED-15 and EDE-Q measure near-identical constructs. The ED-15 
differentiated self-reported eating-disordered and non-clinical groups to the same degree as 
the longer EDE-Q. Session-by-session analysis of the CBT treatment group demonstrated 
that the different ED-15 scales changed in different patterns across therapy. 
Discussion: The ED-15 is not proposed as an alternative to existing measures, but as a 
complementary tool, used to measure session-by-session change for clinical and research 
purposes. Future research will track changes in ED-15 scores across therapy, to determine 
the importance of very early response to therapy and sudden changes. 
 
Keywords: Eating disorders; symptoms; measurement; validation; self-report; questionnaire 
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Development, psychometric properties and preliminary clinical validation of a brief, 
session-by-session measure of eating disorder cognitions and behaviors: The ED-15 
 
The evaluation of therapy outcomes is an important task, whether in research or in 
routine clinical settings. In other fields, there has been a move towards session-by-session 
symptom monitoring as part of this evaluation process, reflecting an understanding that it is 
crucial that clinicians and researchers should monitor what happens during the process of 
therapy. For example, early change can predict remission (1), while µVXGGHQJDLQV¶in therapy 
have a positive impact on alliance and outcome (2-3). Such session-by-session analysis 
requires measures that are brief, freely available and psychometrically robust, and which focus 
on core features and reflect anticipated patterns of change during therapy.   
Such measures are well established in depression and the anxiety disorders. For 
example, the Generalised Anxiety Disorder Assessment (GAD-7 [4]) is a brief self-report 
questionnaire that can be used as a screening tool and as a measure of severity of anxiety. 
Similarly, the Patient Health Questionnaire (PHQ-9 [5]) is a brief measure of severity of 
depression and response to treatment. The utility of those measures is demonstrated by their 
inclusion as core outcome indices in the UK-wide Improving Access to Psychological 
Therapies (IAPT) programme. Other measures have been developed to measure specific 
facets of anxiety, including the Penn State Worry Questionnaire-Short (PSWQ) for 
pathological worry (6), and the Social Phobia Inventory (SPIN) for social phobia (7). These 
measures meet the clinical utility and availability criteria outlined above. Such questionnaires 
can provide ready evidence of progress in therapy (or lack of change, or even deterioration), 
guiding clinicians on the targets for treatment as it progresses. They also afford opportunities 
for more detailed examination of the mechanisms of change during therapy (e.g., early 
change; sudden change; links to the working alliance).  
These brief, session-by-session measures are not yet available for all disorders. In the 
field of the eating disorders, most self-report questionnaires are designed to measure change 
over a longer time frame (typically, a month), are too long for weekly use, or do not reflect the 
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changes that one would expect in the short-term. For example, different versions of the Eating 
Attitudes Test (EAT-40 [8] and EAT-26 [9]) are relatively long and have not been designed to 
reflect short-term change. They are more often used as screening tools to assess eating 
disorder risk in non-clinical populations. Other measures are designed to generate diagnoses 
(10), and are therefore relatively insensitive to change during therapy. Another group of 
measures provide a more comprehensive, multidimensional assessment of eating pathology, 
such as the Eating Pathology Symptoms Inventory (11), the Eating Disorder Inventory (12), 
and the Stirling Eating Disorders Scales (13). However, these are relatively lengthy, making 
them impractical to use on a session-by-session basis. Furthermore, concerns have been 
raised regarding the psychometric properties of some of these multidimensional measures ±
particularly the Stirling Eating Disorder Scales and the Eating Disorders Inventory (14-16). 
Those brief measures that have been developed for the eating disorders focus on diagnostic 
and screening purposes (e.g., Short Evaluation of Eating Disorders [17]), and are not designed 
or able to track cognitive and symptom change during therapy. 
One of the best-established self-report measures of eating disorder pathology is the 
Eating Disorders Examination-Questionnaire (EDE-Q [18-19]). Developed as a self-report 
version of the Eating Disorders Examination (20), the EDE-Q generates frequency ratings for 
key eating disorder behaviors (e.g., binge eating, self-induced vomiting, and laxative misuse) 
as well as four attitudinal subscales (Restraint, Weight Concern, Shape Concern, and Eating 
Concern). The EDE-Q is widely used to assess treatment effectiveness (21-23), and has the 
advantage of being free to use for clinicians. However, the EDE-Q has two drawbacks when 
compared to the development of such instruments in other disorders, as outlined above. First, 
it measures change over the previous 28 days, making it unsuitable for registering shorter-
term change during therapy. Second, it is relatively long compared with measures such as the 
GAD-7 and the PHQ-9, making it less likely to be completed on a session-by-session basis. 
Furthermore, recent post hoc assessments of its psychometric properties have shown that the 
factor structure of the EDE-Q does not match or approximate to the item groupings used in its 
sub-scales (24-26). Its measure of objective bingeing has also been called into question (27). 
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Thus, the clinical utility of the EDE-Q is limited for a variety of reasons, though it remains useful 
as a measure of outcome of therapy for the eating disorders overall (e.g., used monthly, or for 
pre-post therapy change).  
To summarise, there is a need for a brief, clinically accessible measure of eating 
pathology, which can be used for the specific purpose of monitoring session-by-session 
change in core eating disorder behaviors and attitudes. Moreover, that measure needs to be 
psychometrically sound and clinically valid, showing correspondence with established 
measures such as the EDE-Q. Allowing the measurement of session-by-session changes in 
therapy for eating disorders would give such an instrument the potential to determine the 
importance and sequencing of changes in therapy (e.g., early change; sudden gains; link to 
alliance), as demonstrated in other disorders.  
This aim of this study is to report the development and preliminary validation of a brief, 
session-by-session measure of eating pathology that meets the criteria outlined above. The 
factor structure and test-retest reliability of the measure will be established, and it will be 
validated using established clinical indices (diagnosis; levels of eating pathology; depression; 
anxiety). Finally, changes in attitudinal patterns across the course of therapy will be examined, 
to demonstrate the responsiveness of the measure to psychological intervention. 
 
Method 
Design 
 The study used a mixed comparative and correlational design, with a combination of 
cross-sectional and longitudinal data. 
Ethical Considerations 
 This study was reviewed and approved by the Ethics Committee of the Department of 
Psychology, University of Sheffield, UK. 
Initial Development of the ED-15 Items 
 The principle was to develop a brief measure of the core attitudinal items, plus a set of 
behavioral items, to reflect eating pathology over the past week. To ensure content validity, 
THE ED-15 QUESTIONNAIRE              6 
 
the items were developed through an iterative process of generation and reduction, carried 
out by four of the authors (MT, HT, VM and GW). The attitudinal items were generated using 
a corpus of clinical notes and cognitive records that the authors had accumulated in their 
experience of the delivery of psychological therapies for eating disorders, to ensure 
representativeness and validity of the items. The initial pool was generated by each author 
independently, then they were collated. Where two or more items were found to reflect similar 
attitudes, these four authors reached a consensus about which to remove or how to merge 
them. This process resulted in eleven attitudinal items (see Table 1) in the version to be used 
in the analyses below, accompanied by weekly ratings of the frequency of objective binge-
eating and vomiting (episodes across the week) and of restriction, laxative use and exercise 
to lose weight (days per week that these were undertaken). The final set of items is given in 
Appendix A. 
Participants 
 Three samples were used. The first was a large non-clinical group of males and 
females, some of whom completed the measure on two occasions. The second was a self-
reported group of eating-disordered women, where no formal diagnoses were available. The 
final group consisted of formally diagnosed eating disorder patients, undertaking cognitive-
behavioral therapy.  
The non-clinical sample consisted of 438 woman and 93 men (mean age = 30.4 years; 
SD = 12.1; range = 18-71) who volunteered to take part in an online survey relating to eating 
attitudes. They were recruited via a university-wide email that went to all relevant students and 
staff members, asking them to participate by clicking on a weblink that took them directly to 
the survey. Thus, they were all students (undergraduate or postgraduate) or staff members in 
a UK university. Their reported weight and height gave them a mean body mass index (BMI) 
of 23.0 (SD = 4.64). Although the males tended to have a higher BMI than the females, this 
difference did not achieve significance (mean = 24.1 vs 22.8; t = 1.92, P = .051). Of these 
participants, 149 (129 women; 20 men) agreed to participate a second time (one to three 
weeks later) in order to examine test-retest reliability. There were no exclusion criteria for this 
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group, other than being under 18 years of age. 
 The self-reported eating disorder group consisted of 63 women who reported currently 
suffering from eating disorders. These women had a mean reported age of 28.7 years (SD = 
9.97; range = 18-59) and a mean BMI of 22.2 (SD = 6.51; range = 12.7 to 48.2). They were 
recruited via Project Heal, Canada (a support group for eating disorder sufferers), rather than 
via clinics. Therefore, their diagnoses were self-reported rather than clinically confirmed 
(though each reported having been given her diagnosis by a clinician). Each member of that 
RUJDQLVDWLRQ¶VOLVWVHUYZDVVHQWDQHPDLODVNLQJWKHPWRSDUWLFLSDWHE\FOLFNLQJRQWKHUHOHYDQW
weblink. Anybody who reported that they did not have a current eating disorder was excluded 
from the study. One male was also excluded, as he was the only such case and comparison 
would not be possible or meaningful. Of the 63 women, 23 reported that they had a current 
diagnosis of anorexia nervosa (mean age = 28.8 years, SD = 9.00); 13 reported a diagnosis 
of bulimia nervosa (mean age = 26.6 years, SD = 9.54); and 27 reported a diagnosis of eating 
disorder not otherwise specified (EDNOS), including four with binge eating disorder (mean 
age = 30.8 years, SD = 11.2). 
 The final group consisted of 33 women (mean BMI = 23.8, SD = 3.66; mean age = 
30.8 years, SD = 6.20) with formal diagnoses of bulimia nervosa or atypical bulimia nervosa, 
who undertook and completed a ten-session course of cognitive behavioral therapy for their 
eating disorder. They were recruited as a case series of patients who were offered that 
therapy, with the only exclusion criteria being severe self-harm or suicide risk. Each was 
diagnosed using the Eating Disorders Examination (20) by an appropriately trained clinician. 
They completed the ED-15 weekly acroVVWKHFRXUVHRIWKHWKHUDS\7KLVJURXS¶VGDWDZHUH
used to demonstrate the feasibility of weekly completion of the ED-15, to validate the scores 
attained by the self-reported eating-disordered group, to provide test-retest reliability scores 
for that group, and to test the pattern of change in different aspects of psychopathology across 
therapy. 
Measures and Procedure 
 The survey was distributed using Qualtrics survey software. The participants in the 
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non-clinical sample completed four measures at the first time point, and repeated one at the 
second time point for retest purposes. The self-reported eating-disordered group completed 
the same four measures (once only). The clinically diagnosed eating disorder group completed 
the ED-15 weekly over the ten weeks of therapy (alongside other measures completed for 
clinical purposes), with no failures to complete the ED-15. Twenty-three of this last group 
completed the ED-15 twice over the week prior to starting therapy, with a mean and median 
gap of seven days. 
 Eating Disorder-15 (ED-15). This measure was devised for the purposes of this 
research, using item generation methods and aims as outlined above. The original measure 
consisted of 11 attitudinal items and a further five behavioral items (see Table 1 and Appendix 
A). It was completed by all participants, and repeated by the test-retest subsamples. 
 Eating Disorder Examination-Questionnaire (EDE-Q, version 6 [19]). The EDE-Q 
is a well-established 28-item measure of eating attitudes and behaviors over the past 28 days. 
Its psychometric properties are generally acceptable, though they vary across studies (25). Its 
scoring system yields four attitudinal scales (Restraint; Eating Concern; Weight Concern; 
Shape Concern) and a number of behavioral measures (e.g., objective and subjective 
bingeing, vomiting, laxative use). However, factor analysis of the attitudinal items does not 
reflect these four scales, suggesting instead that there are two or three scales (26,28). The 
validity of the behavioral items is also variable when compared with the interview version of 
the measure, with particular concerns regarding the accuracy of the EDE-Q objective bingeing 
measure in some studies (27).  
 Patient Health Questionnaire (PHQ-9 [5]). The PHQ-9 is a nine-item self-report 
measure of depression, designed to be used repeatedly with the same patient to screen and 
to monitor severity of mood state. It is used routinely as a session-by-session tool in 
measurement of depression LQWKH8.¶VIAPT scheme. It has well-established psychometric 
properties.  
 Generalised Anxiety Disorder Questionnaire (GAD-7 [4]). The GAD-7 is a seven-
item measure of anxiety, used to screen and monitor cases. It is also used as a session-by-
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session measure within the IAPT programme. Its psychometric properties are satisfactory. 
Data Analysis 
 The data from the first cohort of women (N = 438) was used to establish the factor 
structure of the attitudinal scales of the ED-15. The focus on females for this purpose reflected 
the gender bias in WKH HDWLQJ GLVRUGHUV PDNLQJ WKH IHPDOHV¶ VFRUHV PRUH SHUWLQHQW WR
understanding eating pathology (without variance caused by inclusion of males). Principal 
components analysis was used, with Varimax and Direct Oblimin rotations, to establish the 
most meaQLQJIXO SRWHQWLDO VFDOHV &URQEDFK¶V alpha was used to establish the internal 
consistency of the resultant scales, and Spearman-Brown coefficients were used to calculate 
their split-half reliability. The data were split into the first and second halves of the listed items 
UDWKHUWKDQWKHµHYHQRGG¶LWHPPHWKRGZKLFKFDQUHVXOWLQGLIIHUHQWRXWFRPHV. The scores 
of non-clinical women (N = 438) and men (N = 93) were compared using independent sample 
t-tests, in order to demonstrate test the validity of the ED-15 (where one would expect higher 
scores among female participants). Test-retest reliability was established XVLQJ 3HDUVRQ¶V
correlation coefficients, separately for men (N = 20) and women (N = 129) who completed the 
measure twice. In this case, it was anticipated that similar levels of reliability would be 
GHPRQVWUDWHGVRWKDWWKHPHDVXUH¶VFKDUDFWHULVWLFVFRXOGEHVKRZQWREHUREXVWUHJDUGOHVV
of gender. The concurrent validity of the ED-15 relative to the EDE-Q and to the measures of 
anxiety and depUHVVLRQ ZDV WHVWHG XVLQJ 3HDUVRQ¶V FRUUHODWLRQV )LQDOO\ WKH concurrent 
validity of the ED-15 was compared to that of the EDE-Q, contrasting the scores of the 438 
non-clinical women with those of the 63 self-reported eating-disordered women, using one-
way ANOVAs (with post hoc Least Significant Difference tests). The self-reported eating-
disordered women were divided into their self-reported diagnostic groups, to determine 
whether there were inter-diagnosis differences or not (the latter possibility being more 
consistent with a transdiagnostic model, where no difference would be expected). All analyses 
were conducted using SPSS v.21. 
 
Results 
THE ED-15 QUESTIONNAIRE              10 
 
Factor Structure of the ED-15 Attitudinal Items 
 In keeping with the exploratory nature of the factor analysis at this initial developmental 
stage, principal components analysis was used to determine the factor structure of the ED-15 
among the 438 women who completed the measure in the main phase of data collection. The 
most meaningful factor structure emerged with a Direct Oblimin rotation, meaning that the 
factors were intercorrelated (component correlation = .551). This association is a common 
pattern with measures of psychopathology, where the resultant dimensions are often 
correlated rather than being orthogonal. The results of this analysis are presented in Table 1. 
The analysis identified two factors, using the criteria of scree analysis and an eigenvalue 
greater than 1.0. They accounted for 62.0% and 10.3% of the variance in scores, respectively. 
______________________________ 
Insert Table 1 about here 
______________________________ 
 
 Ten of the items each loaded clearly onto one of the two factors (factor loading > .5; 
difference of at least .2 between loadings). However, the remaining item (number 5) did not 
load uniquely onto either factor, and was therefore excluded from all further consideration. Six 
items (2, 4, 6, 7, 10, and 11) loaded onto one factor, which was labelled µ:HLJKW	6hape 
CRQFHUQV¶7he other factor consisted of four items (1, 3, 8, and DQGZDVODEHOOHGµEating 
CRQFHUQV¶7KHLQWHUQDOFRQVLVWHQFLHVRIWKHVFDOHVZHUHboth strong (&URQEDFK¶Valpha = .938 
and .802 respectively).  
 The two subscales were scored by taking the item means of the six and four items in 
each scale, and a total score was calculated using the mean of the full set of ten items. The 
mean scores for this female sample are given in Table 1 (possible range of scores = 0-6, with 
higher scores indicating greater eating pathology). The final measure and scoring system are 
given in Appendix A. 
Split-Half Reliability of the ED-15 Attitudinal scores 
 These analyses were undertaken for the first sample as a whole, as results were very 
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similar for males and females separately. The split-half reliability of the scale as a whole was 
satisfactory (Spearman-Brown coefficient = .926). The same was true for the Weight & Shape 
Concerns and the Eating Concerns scales (Spearman-Brown coefficients = 0.926 and .704, 
respectively).  
Norms for the ED-15 and Other Measures 
 Table 2 shows the mean scores for the ED-15, EDE-Q, PHQ-9 and GAD-7 for the 438 
non-clinical women and 93 non-clinical men who completed the main study. In all cases apart 
from the ED-15 behavioral items (which are reported only for those who used the each 
behavior at all), the scores show that the females had significantly greater levels of eating 
pathology, depression and anxiety than the males. The mean scores on the existing measures 
were in the normal range. 
____________________________ 
Insert Table 2 about here 
____________________________ 
 
 In the case of the ED-15 behavioral items, the pattern was that proportionally more 
females than males undertook the behavior. However, in the case of those who undertook 
the behavior at all, there were no differences between men and women in the frequency of 
the behavior (number of episodes; days used per week). 
Test-Retest Reliability of the ED-15 Attitudinal Scales 
Of the participants in the first wave of data collection, 149 (20 male, 129 female) 
undertook the second wave, completing the ED-15 again. The mean gap between completions 
was 18 days (range = 14-3HDUVRQ¶VFRUUHODWLRQVEHWZHHQWLPHDQGtime 2 scores were 
as follows: Overall score: r = .908 (females ± r = .901; males ± r = .934); Weight & Shape 
Concerns: r = .903 (females ± r =.896; males ± r = .922); and Eating Concerns r = .860 
(females ± r = .852; males ± r = .881). All correlations were significant at the P < .001 level.  
Among the 23 women with formally-diagnosed eating disorders who completed the 
measure twice prior to therapy, the test-retest reliability of the Overall ED-15 score was r = 
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.785. Test-retest reliability on the Weight & Shape Concerns scale was r = .788, and the test-
retest reliability of the Eating Concerns scale was r = .806. In all cases, the association was 
strong (P < .001). Given this evidence of the stability of ED-15 scores, it can be concluded 
that changes as a result of therapy are unlikely to be due to random fluctuations. 
Concurrent Validity of the ED-15 Attitudinal and Behavioral Items 
 In order to establish the concurrent validity of the ED-15 among the non-clinical group, 
scores on its scales were correlated with those on the existing, validated EDE-Q scales. 
Furthermore, the ED-15 and EDE-4VFDOHVZHUHHDFKFRUUHODWHGZLWKSDUWLFLSDQWV¶%0,V. Only 
the findings for the sample as a whole are reported, because they were almost identical to 
those for the males and females separately. Table 3 shows the resulting Pearson correlation 
coefficients. It is noteworthy that the correlation between the total scores of the two measures 
was very strong (r = +.889), suggesting that they measure very similar constructs, despite their 
time frames being different.  
____________________________ 
Insert Table 3 about here 
____________________________ 
 
 Considering the correlations between attitudinal subscales, the strongest correlations 
were between the ED-15 Weight & Shape Concerns scale and the EDE-Q Weight Concern 
and Shape Concern scales, supporting the concurrent validity of this ED-15 scale. However, 
the ED-15 Eating Concerns scale was more evenly associated with the four EDE-Q scales. 
For both the EDE-Q and the ED-15, concerns about weight and shape were associated with 
a higher BMI, but other eating attitudes were not, suggesting similarity in the links between 
weight and specific attitudes (and thus, comparability of the EDE-Q and ED-15). 
 For the behavioral scales that could be compared (objective bingeing, vomiting, 
laxative abuse, excessive exercise), the number of non-clinical individuals reporting some 
behaviors differed across measures. On the EDE-Q, 121 individuals reported objective binges, 
but only 100 did so on the ED-15. In contrast, more reported excessive exercise on the ED-
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15 than on the EDE-Q (181 vs 117). However, there was greater concordance between the 
ED-15 and EDE-Q in the numbers who vomited (14 each) and those who used laxatives (six 
vs ten). For those who reported each of the behaviors on both measures, the correlation 
coefficients for frequencies of the behaviors were: objective bingeing - r = +.601; vomiting - r 
= +.789; laxative use - r = +.971; and exercise - r = +.628 (P < .001, in all cases). 
 To summarise, in the non-clinical group, the ED-15 had strong concurrent validity 
(relative to the EDE-Q) in terms of eating attitudes scales, purging behaviors (vomiting and 
laxatives), and BMI. The two measures differed in the number of identified cases where the 
individual binged objectively and where there was excessive exercise, with the EDE-Q 
showing more of the former (in keeping with existing literature [26]) and the ED-15 identifying 
more of the latter. However, in those cases where there was concordance over the presence 
of the relevant behavior, the measures showed a strong agreement over the level of those 
behaviors. 
Convergent Validity of the ED-15 Relative to Non-Eating Pathology Measures 
 In the non-clinical group, 3HDUVRQ¶V correlations were used to determine the 
associations between the two measures of eating attitudes (ED-15 and EDE-Q) and the 
measures of anxiety and depression (GAD and PHQ), in order to demonstrate whether either 
eating measure was superior in reflecting wider psychopathology. These analyses are 
reported for the non-clinical sample as a whole, as there were no differences in outcome when 
conducted separately for females and males. Table 4 shows that the patterns of association 
were similar for the ED-15 and the EDE-Q, with moderate, highly significant correlations 
between the measures of eating and the measures of other anxiety and depression. In both 
cases, the correlation with depression tended to be higher than the association with anxiety. 
To summarise, the ED-15 has comparable concurrent validity to the EDE-Q, based on the two 
PHDVXUHV¶ associations with more general psychopathology. 
____________________________ 
Insert Table 4 about here 
____________________________ 
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Comparability of Scores on the ED-15 and EDE-Q for the Non-Clinical Sample 
 In order to determine the comparability of scores on the two eating measures among 
the first sample, Table 5 shows the scores that represent different percentiles. While these 
scores are not intended to represent any form of translation across measures, it is noteworthy 
that the EDE-Q tended to have lower scores in the normal range for females than the ED-15, 
but that the scores became more similar at the higher end of the distribution. However, that 
move towards similarity was not found among the males.  
____________________________ 
Insert Table 5 about here 
____________________________ 
 
Clinical Validation of the ED-15 
 Table 6 shows the mean scores on the ED-15 and the EDE-Q attitudinal scales of the 
438 non-clinical women and the 63 women with self-reported eating disorders. There were 
similar results for both measures, with the three self-reported diagnostic subgroups (among 
those with a self-reported eating disorder) having significantly higher scores on all scales than 
the non-clinical group. There were no differences between the anorexia nervosa and bulimia 
nervosa groups on most scales. However, there was one pattern of differences between 
diagnoses, with the anorexia nervosa group scoring higher on the EDE-Q Restraint and Eating 
Concern scales and on the ED-15 Eating Concerns scale. To summarise, the ED-15 and EDE-
Q had comparable patterns of clinical validity. 
____________________________ 
Insert Table 6 about here 
____________________________ 
 
 Considering the 33 formally diagnosed eating-disordered women, Table 7 provides 
weekly, session-by-session ED-15 scores across the course of a ten-session cognitive-
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behavioral therapy for individuals with bulimic or atypical normal-weight eating disorders. It is 
noteworthy that the pre-treatment scores of the formally diagnosed group were similar to those 
of the comparable self-reported clinical subgroups in Table 6. The ANOVAs demonstrate that 
the scores on the two ED-15 scales fell over time, as one would hope. However, post-hoc 
multiple comparison tests (P < .05) show that the two scores changed at different time points. 
The Eating Concerns score showed its greatest change between sessions 1-4 and then from 
session 8-10), while the Weight & Shape Concerns score changed most at a later point in the 
therapy (between sessions 3-6, and then again from sessions 8-10). While preliminary, this 
difference in patterns of change indicates the distinctive clinical utility of each ED-15 scale. 
____________________________ 
Insert Table 7 about here 
____________________________ 
 
In order to contextualise these overall changes in ED-15 scores across brief CBT, 
Table 5 shows that the mean scores of the formally-diagnosed eating-disordered group 
changed from between the 90th and 95th centile for non-clinical women (session 1) to below 
the 75th centile (session 10), suggesting substantial reduction in eating disorder cognitions. 
However, it is also important to consider how these changes in ED-15 scores were or were 
not mirrored in other clinical indices. First, WKHFKDQJHLQWKHVDPHSDWLHQWV¶('(-Q scores 
between sessions (session 1: M = 3.99, SD = 1.45; session 1: M = 2.42, SD = 1.32; paired t 
= 3.79, P = .002) was of a comparable degree to that for the ED-ZLWKWKHSDWLHQWV¶PHDQ
scores falling from between the 90th and 95th centile to just below the 75th centile (Table 5). 
Second, the behavioral remission rate (no use of any bingeing or compensatory behaviors by 
the end of therapy) was 48%, suggesting that the change in cognitions was associated with a 
relatively high level of reduction in behaviors. This abstinence level is nearly identical to that 
reported elsewhere for CBT for comparable eating disorders (22). To summarise, the change 
during therapy in ED-15 eating disorder cognitions has been shown to be clinically meaningful, 
relative to other, established outcome indices. 
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Discussion 
This study has reported on the development and initial psychometric and clinical 
validation of the Eating Disorder-15 (ED-15), a brief self-report measure of eating attitudes 
and behaviors, developed for use on a weekly basis in clinical settings. The long-term aim is 
that the measure should be tested for its clinical utility in monitoring therapy process and 
outcomes on a session-by-session basis. As a basis for that work, the present study has 
addressed core psychometric and clinical properties, comparing the ED-15¶V SURSHUWLHV to 
those of the well-established EDE-Q (which is longer, and is used for measuring attitudes and 
behaviors over the previous month). 
A large non-clinical female sample was used to determine that the ED-15 attitudinal 
items have a two-factor structure, resulting in two subscales - µWeight & Shape CRQFHUQV¶DQG
µEating &RQFHUQV¶Each subscale had satisfactory internal consistency, split-half reliability and 
test-retest reliability. 7KHUHZDVDVLPLODUGLIIHUHQFHEHWZHHQPHQ¶VDQGZRPHQ¶VVFRUHVWR
that found on the EDE-Q. The ED-15 scales correlated very highly with the existing, validated 
EDE-Q scales, suggesting that they measure very similar constructs. There was similar 
concordance between the ED-15 and EDE-Q when it came to associations with BMI and levels 
of eating behaviors (though most strongly for purging behaviors). The ED-15 and EDE-Q 
demonstrated similar patterns of association with measures of anxiety (GAD-7) and 
depression (PHQ-9). Overall, these findings indicate that the ED-15 has comparable 
concurrent validity to the EDE-Q. Finally, clinical validation was demonstrated by comparing 
the scores of the original sample with those given by two groups of women with eating 
disorders ± one self-reported, and one formally diagnosed (though with similar scores). Again, 
the level of differentiation between the non-clinical group and the self-reported eating-
disordered group was comparable for the ED-15 and the EDE-Q. As a further indication of the 
ED-¶V FOLQLFDO XWLOLW\ LW ZDV VKRZQ WKDW FKDQJHV DFURVV D EULHI FRXUVH RI &%7 ZHUH
comparable to those shown using other clinical indices, resulting in more normative cogntions. 
Tables 5, 6 and 7 provide norms for use in future research and clinical work. The limitation 
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imposed by the self-reported nature of the eating disorders in the relevant group is important 
to note, though the similarity of scores across the self-reported and comparable formally-
diagnosed group attenuates that concern to a degree. 
In clinical terms, the ED-15 is designed to complement measures such as the EDE-Q, 
rather than to supplant them. Those more detailed questionnaires provide a level of clinical 
detail that is likely to be more appropriate pre- and post-treatment, measuring overall outcome. 
In contrast, the brevity of the ED-15 makes it more suitable for session-by-session use. It is 
free to use, rapidly completed (e.g., at the start of a session or while waiting), and easy to 
score, and norms have been provided to allow clinicians to interpret scores. In addition, the 
ED-15 has a scoring system that has been derived from factor analysis, making it more robust 
than questionnaires such as the EDE-Q and EDI, where factor analysis was applied following 
the implementation of the measure (and not always successfully). As with similar measures of 
other disorders (e.g., depression, anxiety), the ED-15 is intended to be useful for session-by-
session measurement of key eating disorder attitudes and behaviors, allowing the clinician to 
be responsive to change (or lack of it) in the early and later stages of treatment, and explicitly 
to link the tasks of therapy with changes in psychopathology. The scores can be discussed in 
supervision, to ensure that the clinician remains on track with the delivery of evidence-based 
approaches (19,30). The ED-15 is potentially suitable for use in other languages, dependent 
on appropriately rigorous translation processes. A related consideration in future research is 
whether the wording is appropriate use in all English speaking countries, though different 
variants should be used only if justified. Modification might also be needed for children and 
adolescents. A further issue that the ED-15 has in common with other measures (e.g., the 
EDE-Q) is that it is not fully reflective of the range of anorexia nervosa presentations. Its focus 
on issues of weight and shape means that its utility is limited with non-fat-phobic anorexia 
nervosa. There is a need for most such measures to be developed to assess the pathology of 
this subset of anorexia nervosa patients. 
This study found little difference across diagnoses in the ED-15 scores of the self-
reported eating-disordered groups (as well as showing that the self-reported eating-disordered 
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JURXSV¶ VFRUHV ZHUH VLPLODU WR WKRVH RI WKH Fomparable women in the formally-diagnosed 
clinical group). This finding is similar to the outcome of other studies using different measures 
of eating pathology. While this conclusion might appear to be in keeping with the 
transdiagnostic model of the eating disorders (29), it is equally possible that the self-selected, 
self-diagnosed nature of the individuals in question masked true group differences. Therefore, 
this study needs to be replicated with a diagnostically diverse clinical group with confirmed 
diagnoses, which is large enough to allow for confirmatory factor analysis. 
As per the aim of this study, the ED-15 has the potential to inform research into the 
outcome and process of change in therapy. As well as allowing comparison between pre- and 
post-therapy scores (as has been done using measures such as the EDE and EDE-Q [22-
23]), a session-by-session measure can be used to identify change during therapy and its 
implications. Examples might include detecting early cognitive and behavioral responses to 
therapy and sudden changes in behavior, both of which have been found to be important in 
other disorders (1-3). While this measure has a largely cognitive-behavioral origin, so does 
the EDE-Q, and that measure has been used to show effects of other treatments for the eating 
disorders (31-32). Therefore, the ED-15 can be suggested as a within-treatment measure of 
the impact of a range of therapies for the eating disorders. In that context, it could be used to 
YDOLGDWHFOLQLFLDQV¶MXGJHPHQWVUHJDUGLng session-by-session progress. It could also be used 
in combination with real-time assessment measures (33) to determine the possible interaction 
of symptom fluctuation and overall symptom change. Finally, in clinical terms, the ED-15 can 
be used to identify the most effective components of treatment and sequences of changes 
(e.g., does cognitive change predict behavioral change or vice versa; what is the link between 
change in the working alliance and symptoms [34]), thus informing the optimum sequence of 
therapy delivery. However, it should be stressed that the ED-15 is not designed for diagnostic 
or screening purposes, and that other measures are more likely to be useful in this regard 
(10,17). The other potential use of the ED-15 is as a brief measure of eating pathology in 
experimental studies (e.g., priming, the impact of food intake, cognitive dissonance effects), 
where a brief, focused measure is needed as the dependent variable, though this possibility 
THE ED-15 QUESTIONNAIRE              19 
 
clearly needs to be established empirically. 
 
Conclusions 
The ED-15 is a brief, reliable and valid measure of core eating disorder features that 
are commonly addressed in therapy. It is not suggested as an alternative to existing pre- and 
post-treatment measures such as the EDE-Q, but as a complementary tool for measuring 
session-by-session impact of treatment for eating disorders. 
 
 
 
 
Declaration of interests 
The authors have no competing interests.  
THE ED-15 QUESTIONNAIRE              20 
 
References 
1. Crits-Christoph P, Connolly MB, Gallop R, Barber JP, Tu X, Gladis M, Siqueland L. 
Early improvement during manual-guided cognitive and dynamic psychotherapies 
predicts 16-week remission status. J Psychotherapy Pract Res 2001; 10:145-154. 
2. Tang TZ, DeRubeis RJ. Sudden gains and critical sessions in cognitive-behavioral 
therapy for depression. J Consult Clin Psychol 1999; 67:894-904. 
3. Tang TZ, DeRubeis RJ, Beberman R, Pham T. Cognitive changes, critical sessions, and 
sudden gains in cognitive-behavioral therapy for depression. J Consult Clin Psychol 
2005; 73:168-172. 
4. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized 
anxiety disorder: the GAD-7. Arch Int Med, 2006; 166:1092-1097. 
5. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. 
Psychiatric Annals 2002; 32:1-7. 
6. Behar E, Alcaine O, Zuellig AR, Borkovec TD. Screening for generalized anxiety 
disorder using the Penn State Worry Questionnaire: A receiver operating characteristic 
analysis. Journal of Beh Ther Exp Psychiatry 2003; 34:25-43. 
7. Connor KM, Davidson JR, Churchill LE, Sherwood A, Weisler RH, Foa E. Psychometric 
properties of the Social Phobia Inventory (SPIN): New self-rating scale.  Br J Psychiatry 
2000; 176:379-386. 
8. Garner DM, Garfinkel PE. The Eating Attitudes Test: An index of the symptoms of 
anorexia nervosa. Psychol Med 1979; 9:273-279. 
9. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The Eating Attitudes Test: psychometric 
features and clinical correlates. Psychol Med 1982; 12:871-878. 
10. Stice E, Telch CF, Rizvi SL. Development and validation of the Eating Disorder 
Diagnostic Scale: A brief self-report measure of anorexia, bulimia, and binge-eating 
disorder. Psychol Assess 2000; 12:123-131. 
11. Forbush KT, Wildes JE, Pollack LO, Dunbar D, Luo J, Patterson K, Petruzzi L, Pollpeter 
M, Miller H, Stone A, Bright A, Watson D. Development and validation of the Eating 
THE ED-15 QUESTIONNAIRE              21 
 
Pathology Symptoms Inventory (EPSI). Psychol Assess 2013; 25:859-878. 
12. Garner DM, Olmsted MP, Polivy J. Development and validation of a multidimensional 
eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord, 1983; 2:15-
34. 
13. Williams GJ, Power KG, Miller HR, Freeman CP, Yellowlees A, Dowds T, Walker M, 
ParryǦJones WL. Development and validation of the Stirling Eating Disorder Scales. Int J 
Eat Disord 1994; 16:35-43. 
14. Gamble C, Bryant-Waugh R, Turner H, Jones C, Mehta R, Graves A. An investigation 
into the psychometric properties of the Stirling Eating Disorder Scales. Eat Beh, 2006; 
7:395-403. 
15. Openshaw C, Waller G. Psychometric properties of the Stirling Eating Disorder Scales 
with bulimia nervosa patients. Eat Behav 2005; 6:165-168. 
16. Tasca GA, Illing V, Lybanon-Daigle V, Bissada H, Balfour L. Psychometric properties of 
the Eating Disorders Inventory-2 among women seeking treatment for binge eating 
disorder. Assessment 2003; 10:228-236. 
17. Bauer S, Winn S, Schmidt U, Kordy H. Construction, scoring and validation of the Short 
Evaluation of Eating Disorders (SEED). Eur Eat Disord Rev 2005; 13:191-200. 
18. Fairburn CG, Beglin SJ. Assessment of eating disorders: Interview or selfǦreport 
questionnaire? Int J Eat Disord 1994; 16:363-370. 
19. Fairburn CG. Cognitive behavior therapy and eating disorders. New York, NY: Guilford; 
2008. 
20. Cooper Z, Fairburn C. The Eating Disorder Examination: A semiǦstructured interview for 
the assessment of the specific psychopathology of eating disorders. Int J Eat Disord 
1987; 6:1-8. 
21. Byrne SM, Fursland A, Allen KL, Watson H. The effectiveness of enhanced cognitive 
behavioural therapy for eating disorders: An open trial. Beh Res Ther 2011; 49:219-226. 
22. )DLUEXUQ&&RRSHU='ROO+2¶&RQQRU0%ohn K, Hawker D, Wales JA, Palmer R. 
Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: a two-
THE ED-15 QUESTIONNAIRE              22 
 
site trial with 60-week follow-up. Am J Psychiatry 2009; 166:311-319. 
23. Fairburn CG, Cooper Z, Doll HA, O'Connor ME, Palmer RL, Dalle Grave R. Enhanced 
cognitive behaviour therapy for adults with anorexia nervosa: A UK±Italy study. Beh Res 
Ther 2013; 51:R2-R8. 
24. Allen KL, Byrne SM, Lampard A, Watson H, Fursland A. Confirmatory factor analysis of 
the Eating Disorder Examination-Questionnaire (EDE-Q). Eat Beh 2011; 12:143-151. 
25. Berg KC, Peterson CB, Frazier P, Crow SJ. Psychometric evaluation of the Eating 
Disorder Examination and Eating Disorder ExaminationǦQuestionnaire: A systematic 
review of the literature. Int J Eat Dis 2012; 45:428-438. 
26. Waller G, Hamill M, van Gerko K, Hughes ML. Psychometric properties and discriminant 
validity of the Eating Disorders Examination-Questionnaire form. Paper presented at the 
Eating Disorders Research Society. Port Douglas; September 2006. 
27. Black CM, Wilson GT. Assessment of eating disorders: Interview versus questionnaire. 
Int J Eat Disord 1996; 20:43-50. 
28. Peterson CB, Crosby RD, Wonderlich SA, Joiner T, Crow SJ, Mitchell JE, Bardone-
Cone AM, Klein M, le Grange D. Psychometric properties of the Eating Disorder 
ExaminationǦuestionnaire: Factor structure and internal consistency. Int J Eat Disord 
2007; 40:386-389. 
29. Fairburn CG, Cooper Z, Shafran R. Cognitive behaviour therapy for eating disorders: A 
³WUDQVGLDJQRVWLF´WKHRU\DQGWUHDWPHQW%HK5HV7KHU9-528. 
30. Waller G, Cordery H, Corstorphine E, Hinrichsen H, Lawson R, Mountford V, Russell K. 
Cognitive behavioral therapy for eating disorders: A comprehensive treatment guide. 
Cambridge, UK: Cambridge University Press, 2007. 
31. Poulsen S, Lunn S, Daniel SI, Folke S, Mathiesen BB, Katznelson H, Fairburn CG. A 
randomized controlled trial of psychoanalytic psychotherapy or cognitive-behavioral 
therapy for bulimia nervosa. Am J Psychiatry 2014; 171:109-116. 
32. Zipfel S, Wild B, Groß G, Friederich HC, Teufel M, Schellberg D, Giel KE, de Zwaan M, 
Dinkel A, Herpertz S, Burgmer M, Löwe B, Tagay S, von Wietersheim J, Zeeck A, 
THE ED-15 QUESTIONNAIRE              23 
 
Schade-Brittinger C, Schauenburg H, Herzog W. Focal psychodynamic therapy, 
cognitive behaviour therapy, and optimised treatment as usual in outpatients with 
anorexia nervosa (ANTOP study): randomised controlled trial. Lancet 2014; 
383(9912):127-137. 
33. Smyth J, Wonderlich S, Crosby R, Miltenberger R, Mitchell J, Rorty M. The use of 
ecological momentary assessment approaches in eating disorder research. Int J Eat 
Disord 2001;30: 83-95. 
34. Brown A, Mountford VA, Waller G. An idea worth researching: Is the therapeutic alliance 
overvalued in the treatment of eating disorders?  Int J Eat Disord 2013; 46:779-782. 
 
  
THE ED-15 QUESTIONNAIRE              24 
 
Table 1 
Principal components analysis (direct oblimin rotation) of ED-15 items for non-clinical 
females (N = 438), with item mean scores and internal consistency of resulting scales 
 
 
Items Factor 1 Factor 2 
 Over the past week, how often have I: Weight & Shape 
Concerns 
Eating 
Concerns 
1 Worried about losing control over my eating .363 .588 
2 Avoided activities or people because of the way I look .911 -.157 
3 Been preoccupied with thoughts of food and eating .272 .636 
4 &RPSDUHGP\ERG\QHJDWLYHO\ZLWKRWKHUV¶ .784 .111 
5 Been worried that whatever I ate, I would gain lots of 
weight 
.503 .467 
6 Avoided looking at my body (e.g., in mirrors; wearing 
baggy clothes) because of the way it makes me feel 
.921 -.072 
7 Felt distressed about my weight .763 .234 
8 Checked my body to reassure myself about my 
appearance (e.g., weighing myself; using mirrors) 
-.092 .841 
9 Followed strict rules about my eating -.035 .804 
10 Felt distressed about my body shape .814 .152 
11 Worried that other people were judging me as a 
person because of my weight and appearance. 
.864 -.005 
  
Eigenvalue 
 
6.82 
 
1.14 
 Variance explained 62.0% 10.3% 
 &URQEDFK¶Valpha  .938 .802 
 Item mean (SD) 1.79 (1.49) 2.44 (1.37) 
  
THE ED-15 QUESTIONNAIRE              25 
 
Table 2 
Mean scores on measures of eating, anxiety and depression for the non-clinical males and 
females (first sample only) 
 
 Female (N = 438) Male (N = 93) t-test 
ED-15 scale M (SD) M (SD) t P 
Attitudinal scales       
Weight & Shape Concerns  1.79 (1.49) 1.02 (1.28) 4.38 .001 
Eating Concerns  2.44 (1.37) 1.75 (1.22) 4.98 .001 
Total 2.05 (1.33) 1.31 (1.15) 5.32 .001 
Behavioral items (per week)       
Objective binges (82 F; 18 M) 2.57 (1.96) 1.78 (1.06) 1.68 NS 
Vomiting episodes (13 F; 1 M) 2.56 (2.14) 1.00 (-) 0.73 NS 
Laxative use days (6 F; 0 M) 2.83 (1.72) - (-) - - 
Exercise days (143 F; 28 M) 3.28 (1.68) 3.61 (1.64) 0.95 NS 
Restriction days (188 F; 26 M) 4.35 (2.04) 3.88 (2.05) 1.09 NS 
EDE-Q scale  
      
Restraint 1.59 (1.44) 1.11 (1.33) 2.65 .01 
Weight Concern 1.99 (1.62) 0.92 (1.20) 6.56 .001 
Eating Concern 1.07 (1.31) 0.46 (0.88) 4.93 .001 
Shape Concern 1.79 (1.47) 0.98 (1.22) 4.99 .001 
Global 1.61 (1.32) 0.87 (1.00) 5.45 .001 
PHQ 
      
Depression 6.68 (5.76) 5.08 (5.71) 2.27 .025 
GAD 
      
Anxiety 6.24 (5.23) 4.52 (5.21) 2.67 .01 
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Table 3 
3HDUVRQ¶Vcorrelations (r) between ED-15 scales and EDE-Q scales for the whole non-
clinical sample (results were near identical for males and females separately) 
 
 EDE-Q scale  
 
ED-15 scale 
Restraint Eating 
Concern 
Weight 
Concern 
Shape 
Concern 
Global BMI 
Weight & Shape Concerns .550*** .728*** .860*** .884*** .840*** .169*** 
Eating Concerns  .744*** .700*** .721*** .726*** .800*** .043 
Total .674*** .773*** .870*** .888*** .889*** .131** 
BMI .033 .090 .214*** .184*** .152** - 
 
** P < .01; *** P < .001 
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Table 4 
3HDUVRQ¶V correlations (r) between the ED-15 and EDE-Q scales and the GAD anxiety and 
PHQ depression scores for the whole non-clinical sample 
 
 GAD anxiety PHQ depression 
ED-15 scales 
  
Weight & Shape Concerns .520*** .633*** 
Eating Concerns  .412*** .456*** 
Total .517*** .612*** 
EDE-Q scales 
  
Restraint  .305*** .356*** 
Eating Concern .490*** .599*** 
Weight Concern .481*** .568*** 
Shape Concern .504*** .595*** 
Global  .492*** .585*** 
 
*** P < .001 
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Table 5 
ED-15 centile scores for a non-clinical population of adults (range of scores = 0-6), 
compared to similar centiles for EDE-Q scores (range = 0-6) 
 
 Centile point on measure 
Whole group 25th 50th 75th 90th 95th 99th 
EDE-Q Global 0.39 1.14 2.23 3.48 4.15 5.00 
ED-15 Total 0.80 1.65 1.80 2.75 4.50 5.15 
Females 
      
EDE-Q Global 0.49 1.27 2.47 3.62 4.30 5.20 
ED-15 Total 0.90 1.75 2.95 4.00 4.45 5.20 
Males 
      
EDE-Q Global 0.06 0.40 1.36 2.25 2.90 3.25 
ED-15 Total 0.40 0.90 1.80 1.85 4.65 5.00 
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Table 6 
Mean scores on ED-15 and EDE-Q scales for non-clinical and self-diagnosed eating-disordered women 
 
 Non-clinical  
(N = 438) 
Anorexia nervosa 
(N = 23) 
Bulimia nervosa 
(N = 13) 
EDNOS 
(N = 27) 
One-way 
ANOVA 
Least Significant 
Difference tests 
 M (SD) M (SD) M (SD) M (SD) F P (P < .05) 
ED-15 scales 
          
Weight & Shape Concerns  1.79 (1.49) 3.93 (1.35) 4.58 (0.87) 3.77 (1.27) 42.6 .001 NC<AN=BN=EDNOS 
Eating Concerns  2.44 (1.37) 4.66 (0.91) 4.33 (1.10) 3.84 (0.86) 35.5 .001 NC<EDNOS<AN; NC<BN 
Total 2.05 (1.33) 4.22 (1.14) 4.48 (0.90) 3.80    (0.89) 46.7 .001 NC<AN=BN=EDNOS 
EDE-Q scales 
          
Restraint 1.59 (1.44) 4.23 (1.47) 3.60 (1.62) 3.24 (1.62) 37.2 .001 NC<EDNOS<AN; NC<BN 
Weight Concern 1.99 (1.62) 4.49 (1.28) 4.75 (1.34) 4.15 (1.43) 39,9 .001 NC<AN=BN=EDNOS 
Eating Concern 1.07 (1.31) 3.88 (1.39) 3.42 (1.23) 2.89 (1.29) 54.4 .001 NC<EDNOS<AN; NC<BN 
Shape Concern 1.79 (1.47) 4.91 (1.41) 4.95 (1.17) 4.63 (1.20) 43.7 .001 NC<AN=BN=EDNOS 
Global 1.61 (1.32) 4.38 (1.26) 4.18 (1.18) 3.73 (1.16) 53.0 .001 NC<AN=BN=EDNOS 
 
  
THE ED-15 QUESTIONNAIRE              30 
 
Table 7 
Mean session-by-session ED-15 scores across the course of ten-session cognitive-behavioral therapy for formally-diagnosed bulimia nervosa 
and atypical cases (N = 33) 
  
 Session ANOVA 
 1 2 3 4 5 6 7 8 9 10 F P 
Eating concerns 4.68 4.17 4.33 3.75 3.77 3.73 3.75 3.77 2.93 2.77 7.49 .001 
(SD) (0.93) (1.19) (1.01) (1.21) (1.31) (1.43) (1.24) (1.35) (1.44) (1.30)   
Weight and shape concerns 3.94 3.79 3.90 3.46 3.33 3.12 3.36 3.09 2.81 2.55 5.64 .001 
(SD) (1.19) (0.88) (1.03) (1.26) (1.38) (1.51) (1.39) (1.31) (1.42) (1.39)   
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Appendix 1 - ED-15 and scoring key 
ED-15 
This questionnaire considers your eating attitudes and behaviors over the last week. Please 
complete this measure by ticking the appropriate answers for all items. 
 
  
 
 
 
 
 
Over the past week, how often have I: N
o
t a
t a
ll 
Ra
re
ly 
O
cc
a
sio
n
a
lly
 
So
m
e
tim
e
s 
O
fte
n 
M
o
st
 
o
f t
he
 
tim
e 
Al
l t
he
 
tim
e 
1 Worried about losing control over my eating. 
 
0 1 2 3 4 5 6 
2 Avoided activities or people because of the way I 
look 
0 1 2 3 4 5 6 
3 Been preoccupied with thoughts of food and eating 
 
0 1 2 3 4 5 6 
4 &RPSDUHGP\ERG\QHJDWLYHO\ZLWKRWKHUV¶ 
 
0 1 2 3 4 5 6 
5 Avoided looking at my body (e.g., in mirrors; 
wearing baggy clothes) because of the way it 
makes me feel 
0 1 2 3 4 5 6 
6 Felt distressed about my weight 
 
0 1 2 3 4 5 6 
7 Checked my body to reassure myself about my 
appearance (e.g., weighing myself; using mirrors) 
0 1 2 3 4 5 6 
8 Followed strict rules about my eating 
 
0 1 2 3 4 5 6 
9 Felt distressed about my body shape 
 
0 1 2 3 4 5 6 
10 Worried that other people were judging me as a 
person because of my weight and appearance. 
0 1 2 3 4 5 6 
 
If you have never used any of the following behaviors, please respond with N/A.  
For those that you have used, over the past week, how many times have you: Number of 
times 
a Binged (felt out of control of your eating, and eaten far more than a person 
normally would at one go) 
 
b Vomited to control your weight (whether you had to make yourself sick or not) * 
 
 
 
Finally, on how many days in the past week have you: 
Number of 
days 
c Used laxatives to control your weight or shape  
 
d Restricted or dieted in order to control your weight  
 
e Exercised hard in order to control your weight  
 
 
* i.e., Using your fingers or medicines to make yourself sick, or vomiting without such aids 
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ED-15 scoring key 
x All items are positively scored from 0-6. 
x The ED-15 includes two attitudinal subscales, scored as follows: 
o Weight & Shape Concerns = mean of items 2, 4, 5, 6, 9, and 10 (add the six 
scores and divide by 6) 
o Eating Concerns = mean of items 1, 3, 7 and 8 (add the four scores and - 
divide by 4) 
x The Overall attitudinal score is the mean of the scores on all ten items (total the ten 
items and divide by 10). 
x Up to one item can be missed from either scale, and the item mean can be corrected 
accordingly. If more are missing, then the scores are invalid. 
 
 
© 2014 - Turner, Tatham, Mountford & Waller. The ED-15 is free for clinicians and researchers to use. 
To ensure appropriateness, any translations should be discussed with the authors and permission 
obtained. 
 
